Francesco Galimi Adicet Bio, Inc. (ACET) insider trading activity

Francesco Galimi is SVP & Chief Medical Officer of Adicet Bio, Inc.. Currently has a direct ownership of 75,501 shares of ACET, which is worth approximately $68,705. The most recent transaction as insider was on Jan 24, 2024, when has been sold 4,957 shares (Common Stock) at a price of $2.4 per share, resulting in proceeds of $11,896. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 75.5K

0% 3M change

6.16% 12M change

Total Value Held $68,705

Francesco Galimi Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 24 2024	SELL Payment of exercise price or tax liability	$11,896 $2.4 p/Share	4,957 Reduced 6.16%	75,501 Common Stock
Jan 24 2024	BUY Grant, award, or other acquisition	-	26,300 Added 20.53%	101,801 Common Stock
Oct 02 2023	SELL Payment of exercise price or tax liability	$11,087 $1.37 p/Share	8,093 Reduced 9.14%	80,458 Common Stock
Jan 24 2023	BUY Grant, award, or other acquisition	-	26,100 Added 22.76%	88,551 Common Stock
Oct 04 2022	SELL Payment of exercise price or tax liability	$112,807 $14.22 p/Share	7,933 Reduced 11.27%	62,451 Common Stock
Aug 04 2022	SELL Payment of exercise price or tax liability	$100,977 $18.25 p/Share	5,533 Reduced 7.29%	70,384 Common Stock
Aug 04 2022	BUY Grant, award, or other acquisition	-	16,000 Added 17.41%	75,917 Common Stock
Apr 04 2022	SELL Open market or private sale	$167,559 $21.0 p/Share	7,979 Reduced 11.75%	59,917 Common Stock
Apr 04 2022	BUY Exercise of conversion of derivative security	$95,908 $12.02 p/Share	7,979 Added 11.45%	61,692 Common Stock
Apr 01 2022	SELL Open market or private sale	$160,041 $21.0 p/Share	7,621 Reduced 11.28%	59,917 Common Stock
Apr 01 2022	BUY Exercise of conversion of derivative security	$45,497 $5.97 p/Share	7,621 Added 10.14%	67,538 Common Stock
Feb 14 2022	SELL Payment of exercise price or tax liability	$78,956 $14.27 p/Share	5,533 Reduced 8.45%	59,917 Common Stock
Feb 14 2022	BUY Grant, award, or other acquisition	-	16,000 Added 19.64%	65,450 Common Stock
Jan 28 2022	SELL Payment of exercise price or tax liability	$64,681 $11.69 p/Share	5,533 Reduced 10.06%	49,450 Common Stock
Jan 28 2022	BUY Grant, award, or other acquisition	-	16,000 Added 22.54%	54,983 Common Stock
Oct 01 2021	BUY Grant, award, or other acquisition	-	80,000 Added 47.91%	86,983 Common Stock
Jun 04 2021	BUY Exercise of conversion of derivative security	$41,689 $5.97 p/Share	6,983 Added 50.0%	6,983 Common Stock

Francesco Galimi

SVP & Chief Medical Officer

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACET shares.

Notify only if

Value

Insider Trading

Get notified when an Adicet Bio, Inc. insider buys or sells ACET shares.

Notify only if

Operation

Value

Type

News

Receive news related to Adicet Bio, Inc.

Track Activities on ACET

Account